IL-6 as a prognostic biomarker in patients with metastatic melanoma.
L. Hoejberg
No relevant relationships to disclose
L. Bastholt
Consultant or Advisory Role - Merck
J. S. Johansen
No relevant relationships to disclose
K. Fode
No relevant relationships to disclose
H. Schmidt
No relevant relationships to disclose